Active, Not Recruiting
Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.
NCT04157348
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
- Locations
-
- Research Site Denver, Colorado, United States
- Research Site Ann Arbor, Michigan, United States
- Research Site Rochester, Minnesota, United States
- Research Site Albuquerque, New Mexico, United States